-
Mashup Score: 5Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study - 2 year(s) ago
e-DASTHMA is a good tool for the daily assessment of asthma control. This tool can be used as an endpoint in clinical trials as well as in clinical practice to assess fluctuations in asthma control and guide treatment optimisation.
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Could an electronic tool to assess asthma control with a 1-day timeframe be useful for clinical management? - 2 year(s) ago
Asthma is a heterogeneous disease defined in part by a history of respiratory symptoms that vary over time and in intensity. Therefore, symptom assessment is at the core of asthma management,1 and leveraging mobile health (mHealth) apps to remotely monitor it is a promising strategy in clinical practice and research, especially because most of the population owns a smartphone in the present day.2…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
New Linked Comment from Montse Ferrer and Catalina Lizano-Barrantes: "Could an electronic tool to assess #asthma control with a 1-day timeframe be useful for clinical management?" Read it here: https://t.co/V4C8hoKGzG
-
-
Mashup Score: 0
Maysam F Abbod
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
In this month's issue, we say 'thank you' to our statistical and peer reviewers in 2022. Read more here: https://t.co/PgsjsMaXGa
-
-
Mashup Score: 0ChatGPT: friend or foe? - 2 year(s) ago
You would have been hard-pressed to miss the storm surrounding ChatGPT (Chat Generative Pre-trained Transformer) over the past few months. News outlets and social media have been abuzz with reports on the chatbot developed by OpenAI. In response to a written prompt, ChatGPT can compose emails, write computer code, and even craft movie scripts. Researchers have also demonstrated its competency to…
Source: The Lancet Digital HealthCategories: Healthcare Professionals, Latest HeadlinesTweet-
ChatGPT: friend or foe? - The Lancet Digital Health https://t.co/YDUHsBUQTE
-
-
Mashup Score: 5ChatGPT: friend or foe? - 2 year(s) ago
You would have been hard-pressed to miss the storm surrounding ChatGPT (Chat Generative Pre-trained Transformer) over the past few months. News outlets and social media have been abuzz with reports on the chatbot developed by OpenAI. In response to a written prompt, ChatGPT can compose emails, write computer code, and even craft movie scripts. Researchers have also demonstrated its competency to…
Source: The Lancet Digital HealthCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
You would have been hard-pressed to miss the storm surrounding #ChatGPT. Friend or foe, many industries are now grappling with what it means for them—including medicine and health care. An Editorial in @LancetDigitalH delves into the topic: https://t.co/6MSTuRN3Em
-
-
Mashup Score: 24ChatGPT: friend or foe? - 2 year(s) ago
You would have been hard-pressed to miss the storm surrounding ChatGPT (Chat Generative Pre-trained Transformer) over the past few months. News outlets and social media have been abuzz with reports on the chatbot developed by OpenAI. In response to a written prompt, ChatGPT can compose emails, write computer code, and even craft movie scripts. Researchers have also demonstrated its competency to…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
RT @LancetDigitalH: New Editorial: "#ChatGPT: friend or foe?" Read it here: https://t.co/sQV2GBaqm0 https://t.co/pGaOH2cBHu
-
-
Mashup Score: 0Safe care from home for complicated pregnancies? - 2 year(s) ago
There is a move towards greater patient involvement in health care across the world, supported by rapid improvements in self-monitoring technology and widespread accessibility of devices that can be used in telemonitoring, such as smartphones. However, there is a need to understand how to integrate novel interventions into daily practice. Such organisational change can be difficult, and barriers…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
New Linked Comment from Katherine Tucker and @RichardJMcManus: “Safe care from home for complicated pregnancies?” Read it here: https://t.co/ALFF8FnIRf
-
-
Mashup Score: 1
The extent to which patient-reported outcome measures (PROMs) are used in clinical trials for artificial intelligence (AI) technologies is unknown. In this systematic evaluation, we aim to establish how PROMs are being used to assess AI health technologies. We searched ClinicalTrials.gov for interventional trials registered from inception to Sept 20, 2022, and included trials that tested an AI…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
NEW Review evaluating the role of patient-reported outcome measures in trials of #ArtificialIntelligence. Read it here: https://t.co/YVm981ODUD https://t.co/UnLVr12eNX
-
-
Mashup Score: 1Embedding patient-reported outcomes at the heart of artificial intelligence health-care technologies - 2 year(s) ago
Integration of patient-reported outcome measures (PROMs) in artificial intelligence (AI) studies is a critical part of the humanisation of AI for health. It allows AI technologies to incorporate patients’ own views of their symptoms and predict outcomes, reflecting a more holistic picture of health and wellbeing and ultimately helping patients and clinicians to make the best health-care decisions…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
New Viewpoint: “Embedding patient-reported outcomes at the heart of #ArtificialIntelligence health-care technologies”. Read it here: https://t.co/pxrxNhQnG0 https://t.co/sYAcZEnxuB
-
-
Mashup Score: 2US COVID-19 clinical trial leadership gender disparities - 2 year(s) ago
The COVID-19 pandemic has disproportionately affected the careers of women, including those in academia and research. In June, 2020, only 430 (27·8%) of 1548 COVID-19 clinical trials were led by female principal investigators and in August, 2020, only 28·0% of first authors in COVID-19 manuscripts were women.1,2 We sought to analyse disparities in gender, which was assumed from author’s first…
Source: The Lancet Digital HealthCategories: Future of Medicine, Latest HeadlinesTweet-
New Comment from @_gtuli and colleagues: “Trends in US #COVID19 Clinical Trial Leadership Gender Disparities”. Read it here: https://t.co/TJjtoW8BjM
-
NEW Research: "Development and validation of an electronic daily control score for #asthma (e-DASTHMA): a real-world direct patient data study". Read it here: https://t.co/W8f5UCsrPR https://t.co/2GHKUd6B9r